Campbell Wealth Management Bristol Myers Squibb CO Transaction History

Campbell Wealth Management

$1.11 Billion
Q4 2024

A detailed history of Campbell Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Campbell Wealth Management holds 20,066 shares of BMY stock, worth $979,020. This represents 0.1% of its overall portfolio holdings.

Number of Shares

20,066

Previous 6,313 217.85%

Holding current value

$979,020

Previous $327,000 247.09%

% of portfolio

0.1%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$51.92 - $59.94 $714,055 - $824,354	13,753 Added 217.85%	20,066 $1.14 Million
Q3 2024 Oct 28, 2024	BUY	$39.66 - $51.75 $250,373 - $326,697	6,313 New	6,313 $327,000
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $652,911 - $740,275	13,608 Added 215.56%	19,921 $1.08 Million
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $667,569 - $796,594	-13,770 Reduced 68.57%	6,313 $324,000
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $1.28 Million - $1.42 Million	20,083 New	20,083 $1.28 Million
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $8,082 - $9,167	-123 Reduced 0.57%	21,480 $1.49 Million
Q4 2022 Jan 10, 2023	BUY	$68.48 - $81.09 $3,697 - $4,378	54 Added 0.25%	21,603 $1.55 Million
Q3 2022 Oct 11, 2022	BUY	$0.13 - $76.84 $1,759 - $1.04 Million	13,538 Added 168.99%	21,549 $1.53 Million
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $981,749 - $1.08 Million	-13,519 Reduced 62.79%	8,011 $617,000
Q4 2021 Jan 27, 2022	BUY	$53.63 - $62.52 $1.15 Million - $1.35 Million	21,530 New	21,530 $1.34 Million
Q3 2021 Dec 22, 2022	BUY	$59.17 - $69.31 $47,158 - $55,240	797 Added 3.7%	22,346 $1.32 Million
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $1.32 Million - $1.55 Million	-22,346 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $12,815 - $13,955	-207 Reduced 0.92%	22,346 $1.49 Million
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $12,283 - $13,815	207 Added 0.93%	22,553 $1.42 Million
Q4 2020 Jan 19, 2021	SELL	$57.74 - $65.43 $197,239 - $223,508	-3,416 Reduced 13.26%	22,346 $1.39 Million
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $80,402 - $89,096	1,400 Added 5.75%	25,762 $1.55 Million
Q2 2020 Jul 23, 2020	SELL	$54.82 - $64.09 $4,988 - $5,832	-91 Reduced 0.37%	24,362 $1.43 Million
Q1 2020 Apr 17, 2020	SELL	$46.4 - $67.43 $78,880 - $114,631	-1,700 Reduced 6.5%	24,453 $1.36 Million
Q4 2019 Jan 15, 2020	SELL	$49.21 - $64.19 $55,016 - $71,764	-1,118 Reduced 4.1%	26,153 $1.68 Million
Q2 2019 Aug 09, 2019	BUY	$44.62 - $49.34 $9,414 - $10,410	211 Added 0.78%	27,271 $1.24 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $47,827 - $57,028	-1,060 Reduced 3.77%	27,060 $1.29 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $1.37 Million - $1.78 Million	28,120 New	28,120 $1.46 Million

Others Institutions Holding BMY

# of Institutions

2,809

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Wealth Management with notifications on news.

Account

Campbell Wealth Management Bristol Myers Squibb CO Transaction History